INTS · INTENSITY THERAPEUTICS, INC.

Intensity Therapeutics Inc Is A Late-Stage Clinical Biotechnology Company Passionately Committed To Applying Scientific Leadership In The Field Of Localized Cancer Reduction To Anti-Cancer Immune Activation. Its New Approach Involves The Direct Injection Into Tumors Of A Product Created From Dfuserxsm Discovery Platform. Its Platform Creates Patented Anti-Cancer Product Candidates Comprising Active Anti-Cancer Agents And Amphiphilic Molecules. Its Product Candidate, Int230-6 Comprised Of Three Components: Cisplatin, A Anti-Cancer Cytotoxic Agent, Vinblastine Sulfate, Also A Anti-Cancer Cytotoxic Agent, And An Amphiphilic Molecule Which Enables The Two Cytotoxic Agents To Disperse Through A Tumor And Diffuse Into Cancer Cells Following A Direct Intratumoral Injection.